Ergonovine versus ergotamine as a terminator of migraine headaches

被引：19

作者：

Lennox, WG ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA USA

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1938年 / 195卷 / 04期

关键词：

D O I：

10.1097/00000441-193804000-00005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：458 / 468

页数：11

共 30 条

[1] A study of a new and potent ergot derivative, ergotocin [J].

Adair, FL ;

Davis, ME ;

Kharasch, MS ;

Legault, RR .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1935, 30 :466-480

[2]

BARGER G, 1931, ERGOT ERGOTISM LONDO

[3] The effect of non-sedative drugs and other measures in migraine. With especial reference to ergotamin tartrate. [J].

Brock, S ;

O'Sullivan, M ;

Young, D .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1934, 188 :253-260

[4] A new active principle in ergot and its effects on uterine motility - A preliminary report [J].

Davis, ME ;

Adair, FL ;

Rogers, G ;

Kharasch, MS ;

Legault, RR .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1935, 29 :155-167

[5] The substance responsible for the traditional clinical effect of ergot [J].

Dudley, HW ;

Moir, C .

BRITISH MEDICAL JOURNAL, 1935, 1935 :520-523

[6]

DUDLEY HW, 1935, P ROY SOC LOND B BIO, V116, P478

[7]

EDMUNDS CW, 1936, CUSHNYS PHARM THERAP

[8]

Freeman H, 1936, J PHARMACOL EXP THER, V58, P409

[9]

Gould SE, 1936, J AMER MED ASSOC, V106, P1631

[10]

GRAHAM JR, 1937, J CLIN INVEST, V16, P660

← 1 2 3 →